The Patient Partnership Index is a ground-breaking initiative from specialist health communications agency OVID Health.
The inaugural Patient Partnership Index was launched in May 2020, offering pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their communications and advocacy with patient groups.
The Index offers patient groups, pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their partnerships. The aim is to celebrate as many partnerships that meet the mark as possible so we can continue to raise the bar across the industry.
The Index will evaluate the highest standards, based on best practice, of partnerships in communications, advocacy, market access and uptake, clinical trials and R&D between pharmaceutical, biotech and patient communities.
Each company or patient group can submit up to three entries for in-market, regional or global projects. This includes patient advocacy, communications, public affairs, medical affairs, clinical trials and R&D partnerships. There are no costs involved – entering the Index is completely free for everyone.
In return for submitting entries to the Index, entrants will be recognised by industry and patient organisation peers, for their commitment to putting patients at the heart of their work.
All entrants will have the opportunity to profile their involvement with the Index through their own external and internal channels, and awards for GOLD, SILVER and FINALIST standard entries will be announced by OVID Health to celebrate those companies who both demonstrate and lead best practice in patient partnerships.